About Dr. Thomas Hornberger
Thomas Hornberger is associate in our Global Transactions practice group (Corporate/M&A).
He advises national and international clients on M&A-transactions and general corporate matters, in particular he is a member of our sector group General Industries (automotive, chemical, general industry and technology).
Thomas Hornberger speaks German, English and Spanish.
Advising Tower International, Inc., world's leading manufacturer of structural components and body assemblies, on the sale of its European business to Financière SNOP Dunois S.A., a French automotive supplier.
Advising Advent International, one of the world's largest and most experienced private equity investors, on the acquisition of the methacrylates business of Evonik Industries AG (Evonik) for €3 billion.
Advising Bristol-Myers Squibb Company on the disposal of Celgene Corporation's Otezla business to Amgen Inc. for $13,4 billion.
Advising Lloyd Banks Group PLC (Scottish Widows / Clerical Medical) in relation to customer claims based on the revocation of life insurance policies.
Advising Vinnolit GmbH & Co. KG, one of the world's leading specialty chemicals manufacturers, on corporate and environmental law issues.
Advising Microsoft Corporation on ongoing corporate law matters (e.g. mergers).
Advising VEM Vermögensverwaltung GmbH (Merckle group) on ongoing corporate restructuring matters (e.g. mergers and demergers).
Legal education at the Universität Regensburg (first state examination)
Legal trainee (Rechtsreferendar) at the Higher Regional Court of Nuremberg (second state examination)
Doctoral thesis on the subject of "Legal form preserving transfer of registered seat, mergers and changes of legal form of partnerships within the EU - an analysis de lege lata and de lege ferenda" at the University of Regensburg (summa cum laude)